½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

  • »¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

    021-54845833/15800441009

    Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

    µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹CDK2(Phospho-Thr160)¶à¿Ë¡¿¹Ìå

    ²úÆ·ÖÐÐÄ

    ×îвúÆ·

    • Íÿ¹CDK2(Phospho-Thr160)¶à¿Ë¡¿¹Ìå

      ¹æ¸ñ£º
      ¼Û¸ñ£º£¤
      • Æ·ÅÆ : ͨεÉúÎï
      • Ŀ¼ºÅ : TW5484
      • Ó¦Óà : ½öÓÃÓÚ¿ÆÑÐʹÓÃ
      • »õÆÚ : ÏÖ»õ
      • ¹æ¸ñ £º100ul/200ul/25ul
    • ÉÌÆ·ÏêÇé
    • ²Î¿¼ÎÄÏ×
    • ˵Ã÷ÊéÏÂÔØ
    • ÉÌÆ·ÆÀÂÛ0
    • Ïà¹Ø²úÆ·

    ÖÐÎÄÃû³Æ£ºÍÿ¹CDK2(Phospho-Thr160)¶à¿Ë¡¿¹Ìå

    Ó¢ÎÄÃû³Æ£º Anti-CDK2(Phospho-Thr160) polyclonal antibody

    ±ð      Ãû£º cyclin dependent kinase 2; CDKN2; p33(CDK2)

    Ïà¹ØÀà±ð£º Ò»¿¹

    ´¢      ´æ£º Àä¶³£¨-20¡æ£©

    ËÞ      Ö÷£º Rabbit

    ¿¹      Ô­£º CDK2(Phospho-Thr160)

    ·´Ó¦ÖÖÊô£º Human Mouse Rat

    ±ê ¼Ç Î Unconjugate

    ¿Ë¡ÀàÐÍ£º
    rabbit polyclonal

    ¼¼Êõ¹æ¸ñ

    Background:

    This gene encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. The encoded protein is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This protein associates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B)

    Applications:

    WB, IHC

    Name of antibody:

    CDK2(Phospho-Thr160)

    Immunogen:

    Peptide sequence around phosphorylation site of threonine 160 (T-Y-T(p)-H-E) derived from Human CDK2

    Full name:

    cyclin-dependent kinase 2

    Synonyms:

    CDKN2; p33(CDK2)

    SwissProt:

    P24941

    IHC positive control:

    Human breast carcinoma

    IHC Recommend dilution:

    50-100

    WB Predicted band size:

    34 kDa

    WB Positive control:

    Hela cells treated with UV

    WB Recommended dilution:

    500-1000






    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿